Medical Weight Management with GLP-1

Parkway Shenton's Medical Weight Management Programme is a clinically supervised, outcome-driven approach to obesity and overweight that addresses the biological drivers of weight gain — not just lifestyle. Priced from SGD 380 per month, the programme is available at selected Parkway Shenton clinics across Singapore and begins with a comprehensive medical assessment before any treatment is prescribed.

The centrepiece of the programme for eligible patients is GLP-1 receptor agonist therapy. GLP-1 medications (such as semaglutide, marketed as Ozempic or Wegovy, or liraglutide as Saxenda) work by mimicking the natural glucagon-like peptide-1 hormone, which regulates blood sugar, slows gastric emptying, and significantly reduces appetite and food cravings. The medications are typically administered once weekly via subcutaneous self-injection, with dosage…

Beyond medication, the programme integrates personalised nutrition guidance from registered dietitians, an exercise prescription suited to the patient's current fitness level and health status, and regular progress reviews with the supervising doctor. The medical team monitors blood glucose, blood pressure, lipids, and kidney function throughout — essential for safe GLP-1 use in patients with metabolic comorbidities.